Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|August 5, 2024
Expression of integrin α<sub>v</sub>β<sub>3</sub> in medullary thyroid carcinomaLisa H de Vries, Lutske Lodewijk, Emma W Pijnappel, et al.
Neuroendocrinology|September 24, 2020
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus StatementBruno Niederle, Andreas Selberherr, Detlef K Bartsch, et al.
Endocrine|August 22, 2018
SSTR2A expression in medullary thyroid carcinoma is correlated with longer survivalLisa H de Vries, Lutske Lodewijk, Stefan M Willems, et al.
Journal of Neuroendocrinology|November 26, 2024
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire studyCarolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Nature Medicine|September 11, 2019
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Nature Medicine|July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Cancer Cell|December 12, 2023
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sitesTalya L Dayton, Nicolas Alcala, Laura Moonen, et al.
Pageof 14